GPC2-CAR T cell therapy

· Stanford University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GPC2-CAR T cell therapy, covering 2026-01-27 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults [Phase 1]